Summit Therapeutics plc Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Summit Therapeutics plc in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Summit Therapeutics plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Summit Therapeutics plc | - | - | - | - | - | - | - |
| Proteome Sciences | - | 0.000% | 13.725% | -10.769% | 0.000% | -7.937% | 48.718% |
| Oxford BioMedica PLC | - | 4.469% | 12.651% | 1.630% | -26.667% | -37.667% | -56.072% |
| Sareum Holdings plc | 0.670% | 0.000% | -11.243% | -69.880% | -50.331% | -93.852% | - |
News
Is Beaten-Down Summit Therapeutics Stock a Bad-News Buy?
Shares of Summit Therapeutics (NASDAQ: SMMT) tanked more than 30% on Friday, May 30. Such dramatic price swings aren't unusual in the biotechnology industry; in this case, disappointing data from an
Why Summit Therapeutics Plunged Today
Shares of Summit Therapeutics (NASDAQ: SMMT) have plunged 31% as of 1:23 p.m. ET Friday, following the release of some trial data this morning.
Summit has been a tremendous winner over the past
3 High-Flying Stocks That Could Soar Even More
Many investors love the "big mo." That's short for "big momentum." Stocks that are on a roll often keep the good times going.
Three Fool.com contributors think they've found high-flying biotech